Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ

CompletedOBSERVATIONAL
Enrollment

371

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

January 15, 2022

Study Completion Date

September 15, 2022

Conditions
Covid19, Patient Reported Outcome Measures, Quality of Life
Interventions
OTHER

No intervention. Method study. Psychometric testing

Patients will fill in the questionnaire followed by an interview (phase IIIA) or a debriefing questionnaire (Phase IIIB)

Trial Locations (1)

N-0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

collaborator

Medical University Innsbruck

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

Servicio de Navarro de Salud

UNKNOWN

collaborator

University of Southampton

OTHER

collaborator

Skane University Hospital

OTHER

collaborator

Haukeland University Hospital

OTHER

collaborator

University of the East Ramon Magsaysay Memorial Medical Center

UNKNOWN

collaborator

Sumandeep Vidyapeeth

OTHER

collaborator

Birzeit University

UNKNOWN

collaborator

National Centre for Infectious Diseases

UNKNOWN

collaborator

Komfo Anokye Teaching Hospital

OTHER

lead

Oslo University Hospital

OTHER

NCT04740372 - Development of an International COVID-19 Specific Quality of Life Questionnaire, Phase III. The OSLO COVID-19 QLQ | Biotech Hunter | Biotech Hunter